Literature DB >> 29767218

Management of Emotionally Challenging Responses of Hospitalized Patients with Cancer.

Yelena Burklin1, Daniel P Hunt1.   

Abstract

Cancer is the second leading cause of death in the United States, and the majority of hospital admissions of patients with cancer occur because of uncontrolled, urgent symptoms. In addition to complex physical presentations, these patients often manifest a number of complex emotional and psychological responses resulting in a unique set of healthcare needs and expectations. Inpatient generalists or hospitalists frequently serve as the primary providers of medical care for these patients. Formal training for nononcologists on effective communication strategies in managing patients with cancer in a hospital setting may not fully prepare generalists for challenging patient encounters, however. This review assists generalists in approaching emotionally charged encounters when caring for patients with cancer on the wards. We explore patient factors that negatively affect successful communication, some of which can be addressed through a multidisciplinary approach. In addition, we present a checklist of preventive strategies in addressing emotionally charged patient responses and offer a number of preventive and restorative management approaches for dealing with such encounters. We provide a practical framework for recognition and management of the psychosocial and emotional challenges in the care of hospitalized patients with cancer.

Entities:  

Mesh:

Year:  2018        PMID: 29767218     DOI: 10.14423/SMJ.0000000000000809

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  1 in total

1.  Acute effect of orange chromatic environment on perceived health status, pain, and vital signs during chemotherapy treatment.

Authors:  Paula Gómez-Vela; Margarita Pérez-Ruiz; María Fátima Hernández Martín; Javier Román; Eneko Larumbe-Zabala
Journal:  Support Care Cancer       Date:  2019-09-03       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.